• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌的壁层和腹膜定位:根治性手术是否可行?

Parietal and peritoneal localizations of hepatocellular carcinoma: is there a place for a curative surgery?

作者信息

Portolani Nazario, Baiocchi Gian Luca, Gheza Federico, Molfino Sarah, Lomiento Daniele, Giulini Stefano Maria

机构信息

Department of Clinical and Experimental Sciences, Surgical Clinic, University of Brescia, Brescia, Italy.

出版信息

World J Surg Oncol. 2014 Sep 25;12:298. doi: 10.1186/1477-7819-12-298.

DOI:10.1186/1477-7819-12-298
PMID:25255984
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4190395/
Abstract

BACKGROUND

The clinical course of peritoneal and parietal recurrence of hepatocellular carcinoma (HCC-PPL) is not well known.

METHODS

Twenty-eight patients with a histologically proven HCC-PPL were analyzed out of a series of 515 patients operated for HCC (group 1). The risk factors, histological features, growing dynamic and results of surgical treatment were analyzed and compared with patients having other extrahepatic localizations of HCC (group 2; 26 patients). Survival data were also compared with patients with intrahepatic-only recurrence (group 3; 211 patients).

RESULTS

In group 1, a needle tract injury was present in 57.1% and a previous spontaneous rupture in 14.3% of cases. Parietal seeding was generally single, while peritoneal seeding was frequently multiple. Grading was poor in 84.7%, microvascular infiltration was observed in 57.1% and a rapid growth in 55.5% of cases. In Group 2, only 4 out of 26 patients underwent surgery. Survival was significantly better in group 3 than in group 1, and in group 1 than in group 2.

CONCLUSIONS

Extrahepatic HCC recurrence is related to an aggressive biology of the cancer; many characteristics of high malignancy are usually present in these cases. After radical surgery for HCC-PPL, an acceptable survival may be obtained.

摘要

背景

肝细胞癌腹膜和壁层复发(HCC-PPL)的临床病程尚不清楚。

方法

在515例接受肝癌手术的患者系列中,分析了28例经组织学证实为HCC-PPL的患者(第1组)。分析了危险因素、组织学特征、生长动态和手术治疗结果,并与肝癌其他肝外定位的患者(第2组;26例患者)进行比较。生存数据也与仅肝内复发的患者(第3组;211例患者)进行比较。

结果

在第1组中,57.1%的病例存在针道损伤,14.3%的病例有既往自发性破裂。壁层种植通常为单发,而腹膜种植常为多发。84.7%的病例分级较差,57.1%的病例观察到微血管浸润,55.5%的病例生长迅速。在第2组中,26例患者中只有4例接受了手术。第3组的生存率明显高于第1组,第1组的生存率高于第2组。

结论

肝外肝癌复发与癌症的侵袭性生物学有关;这些病例通常具有许多高恶性特征。对HCC-PPL进行根治性手术后,可获得可接受的生存率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fbf/4190395/ccfe1fd1be19/12957_2013_1770_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fbf/4190395/69e8d230eeb7/12957_2013_1770_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fbf/4190395/91eafc1aeb07/12957_2013_1770_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fbf/4190395/ccfe1fd1be19/12957_2013_1770_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fbf/4190395/69e8d230eeb7/12957_2013_1770_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fbf/4190395/91eafc1aeb07/12957_2013_1770_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fbf/4190395/ccfe1fd1be19/12957_2013_1770_Fig3_HTML.jpg

相似文献

1
Parietal and peritoneal localizations of hepatocellular carcinoma: is there a place for a curative surgery?肝细胞癌的壁层和腹膜定位:根治性手术是否可行?
World J Surg Oncol. 2014 Sep 25;12:298. doi: 10.1186/1477-7819-12-298.
2
Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma: review of 1222 cases of hepatectomy in a tertiary institution.肝癌肝切除术后腹膜复发的危险因素及再切除治疗效果:一家三级医疗机构 1222 例肝切除病例回顾。
Ann Surg Oncol. 2012 Jul;19(7):2246-55. doi: 10.1245/s10434-012-2260-3. Epub 2012 Mar 9.
3
Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.中国单中心经验:复发性肝细胞癌患者再次肝切除的长期结果及复发类型分析和其预后。
Ann Surg Oncol. 2012 Aug;19(8):2515-25. doi: 10.1245/s10434-012-2269-7. Epub 2012 Mar 7.
4
Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma.根治性肝切除术后肝细胞癌肝外复发的预测因素。
Ann Surg Oncol. 2010 Oct;17(10):2740-6. doi: 10.1245/s10434-010-1076-2. Epub 2010 Apr 22.
5
Implication of microscopic and macroscopic vascular invasion for liver resection in patients with hepatocellular carcinoma.微观和宏观血管侵犯对肝细胞癌患者肝切除的影响。
Dig Surg. 2014;31(3):204-9. doi: 10.1159/000365257. Epub 2014 Sep 2.
6
Clinicopathologic features and risk factors for extrahepatic recurrences of hepatocellular carcinoma after curative resection.根治性切除术后肝细胞癌肝外复发的临床病理特征及危险因素。
World J Surg. 2012 Jan;36(1):136-43. doi: 10.1007/s00268-011-1317-y.
7
Validation of hepatectomy for elderly patients with hepatocellular carcinoma.老年肝细胞癌患者肝切除术的验证
Ann Surg Oncol. 2015 Sep;22(9):3094-101. doi: 10.1245/s10434-014-4350-x. Epub 2015 Jan 13.
8
Microvascular infiltration has limited clinical value for treatment and prognosis in hepatocellular carcinoma.微血管浸润在肝细胞癌的治疗和预后方面临床价值有限。
World J Surg. 2014 Jul;38(7):1769-76. doi: 10.1007/s00268-013-2426-6.
9
Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.根治性意向下接受部分肝切除术的肝细胞癌患者无病生存和总生存的预后因素。
Langenbecks Arch Surg. 2018 Nov;403(7):851-861. doi: 10.1007/s00423-018-1715-9. Epub 2018 Sep 28.
10
The significance of classifying microvascular invasion in patients with hepatocellular carcinoma.肝细胞癌患者微血管侵犯的分类意义。
Ann Surg Oncol. 2014 Mar;21(3):1002-9. doi: 10.1245/s10434-013-3376-9. Epub 2013 Nov 20.

引用本文的文献

1
Machine learning models for predicting postoperative peritoneal metastasis after hepatocellular carcinoma rupture: a multicenter cohort study in China.预测肝细胞癌破裂后术后腹膜转移的机器学习模型:一项中国的多中心队列研究。
Oncologist. 2025 Jan 17;30(1). doi: 10.1093/oncolo/oyae341.
2
A case of successful surgical treatment for peritoneal seeding of hepatocellular carcinoma after radiotherapy and atezolizumab plus bevacizumab combination treatment.1例肝细胞癌放疗及阿替利珠单抗联合贝伐珠单抗治疗后腹膜种植转移的成功手术治疗病例。
J Liver Cancer. 2023 Mar;23(1):206-212. doi: 10.17998/jlc.2023.02.09. Epub 2023 Feb 24.
3

本文引用的文献

1
Risk factors, clinical features, and prognosis of the hepatocellular carcinoma with peritoneal metastasis.具有腹膜转移的肝细胞癌的风险因素、临床特征和预后。
Dig Dis Sci. 2012 Mar;57(3):813-9. doi: 10.1007/s10620-011-1995-1. Epub 2011 Dec 7.
2
Treatment and clinical outcome of needle-track seeding from hepatocellular carcinoma.肝细胞癌针道种植的治疗及临床结局
Korean J Hepatol. 2011 Jun;17(2):106-12. doi: 10.3350/kjhep.2011.17.2.106.
3
Clinical features and risk factors of extrahepatic seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma.
Clinical course and role of embolization in patients with spontaneous rupture of hepatocellular carcinoma.
肝细胞癌自发性破裂患者的临床病程及栓塞治疗的作用
Front Oncol. 2022 Sep 5;12:999557. doi: 10.3389/fonc.2022.999557. eCollection 2022.
4
Clinical impact of surgical treatment for the spontaneously ruptured resectable hepatocellular carcinoma: A single institution experience.手术治疗自发破裂可切除肝细胞癌的临床影响:单中心经验。
Medicine (Baltimore). 2022 Sep 2;101(35):e30307. doi: 10.1097/MD.0000000000030307.
5
Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know?破裂性肝细胞癌:介入放射科医生需要了解什么?
Front Oncol. 2022 Jun 16;12:927123. doi: 10.3389/fonc.2022.927123. eCollection 2022.
6
Favorable control of hepatocellular carcinoma with peritoneal dissemination by surgical resection using indocyanine green fluorescence imaging: a case report and review of the literature.应用吲哚菁绿荧光成像行手术切除治疗伴腹膜播散的肝细胞癌取得良好疗效:病例报告及文献复习。
J Med Case Rep. 2022 Jun 6;16(1):222. doi: 10.1186/s13256-022-03440-5.
7
Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers.高氨血症性脑病模拟纤维板层肝细胞癌的鸟氨酸转氨甲酰酶缺乏症:连续静脉-静脉血液滤过和氨清除剂治疗成功。
Cancer Res Treat. 2021 Jan;53(1):283-288. doi: 10.4143/crt.2020.575. Epub 2020 Sep 7.
8
Inhibition of Regulatory Volume Decrease Enhances the Cytocidal Effect of Hypotonic Shock in Hepatocellular Carcinoma.抑制调节性容积减小可增强低渗休克对肝癌细胞的杀伤作用。
J Cancer. 2016 Jul 8;7(11):1524-33. doi: 10.7150/jca.15181. eCollection 2016.
经皮射频消融治疗肝细胞癌后肝外播散的临床特征和危险因素。
Hepatol Res. 2011 Aug;41(8):738-45. doi: 10.1111/j.1872-034X.2011.00841.x. Epub 2011 Jun 23.
4
Peritoneal seeding of hepatocellular carcinoma: clinicopathological characteristics of 17 autopsy cases.肝癌腹膜种植转移 17 例临床病理分析
Pathol Int. 2011 Jun;61(6):356-62. doi: 10.1111/j.1440-1827.2011.02669.x. Epub 2011 Apr 27.
5
Hepatocellular carcinoma peritoneal metastases: report of three cases and collective review of the literature.肝细胞癌腹膜转移:三例报告并文献复习。
Ann Acad Med Singap. 2010 Sep;39(9):734-4.
6
Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma.根治性肝切除术后肝细胞癌肝外复发的预测因素。
Ann Surg Oncol. 2010 Oct;17(10):2740-6. doi: 10.1245/s10434-010-1076-2. Epub 2010 Apr 22.
7
Sequential multidisciplinary treatment of hepatocellular carcinoma: the role of surgery as rescue therapy for failure of percutaneous ablation therapies.肝细胞癌的序贯多学科治疗:手术作为经皮消融治疗失败后的挽救性治疗的作用。
J Surg Oncol. 2009 Dec 1;100(7):580-4. doi: 10.1002/jso.21375.
8
Clinical manifestations and survival of hepatocellular carcinoma patients with peritoneal metastasis.肝细胞癌腹膜转移患者的临床表现与生存情况
J Gastroenterol Hepatol. 2009 May;24(5):815-20. doi: 10.1111/j.1440-1746.2009.05848.x.
9
Outcomes and factors influencing survival in cirrhotic cases with spontaneous rupture of hepatocellular carcinoma: a multicenter study.肝细胞癌自发性破裂肝硬化病例的生存结局及影响因素:一项多中心研究
BMC Gastroenterol. 2009 Apr 30;9:29. doi: 10.1186/1471-230X-9-29.
10
Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma.肝细胞癌射频消融术后的肿瘤种植
Am J Gastroenterol. 2008 Dec;103(12):3057-62. doi: 10.1111/j.1572-0241.2008.02153.x.